{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-042440","form_type":"8-K","ticker":null,"cik":"0001394319","company_name":"Tracon Pharmaceuticals, Inc.","filed_at":"2024-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.217580+00:00","generated_at":"2026-06-04T01:19:09.746818+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TRACON (TCON) implements 1-for-20 reverse stock split effective April 9, 2024","bullets":["Board approved 1-for-20 reverse stock split; effective 5:00 p.m. ET on April 9, 2024.","Post-split shares approx. 2.6 million; trading on split-adjusted basis from April 10, 2024.","No fractional shares; holders entitled to fractional share will receive one full post-split share.","Proportional adjustments to options, warrants, and equity plans; authorized shares unchanged at 60M.","New CUSIP 89237H308; symbol TCON continues on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-042440","json":"https://secwatch.observer/filing/0000950170-24-042440.json","markdown":"https://secwatch.observer/filing/0000950170-24-042440.md","text":"https://secwatch.observer/filing/0000950170-24-042440.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024042440/0000950170-24-042440-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024042440/tcon-20240408.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:19:09.746818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58c18b3e4bf2963e342e83b7d6dc94b11b95926c","claim":"Tracon Pharmaceuticals, Inc.: Amended Certificate of Incorporation to effect a one-for-twenty reverse stock split (effective 2024-04-09).","evidence_excerpt":"On April 8, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment of its Amended and Restated Certificate of Incorporation (the “Charter Amendment”) to effect the one-for-twenty reverse stock split of the Company’s outstanding common stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024042440/0000950170-24-042440-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}